Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial

INTRODUCTION: In a randomized controlled trial, we previously investigated if melanoma patients receiving checkpoint inhibitors had fewer severe immune-related adverse events (irAEs) when they reported symptoms using electronic patient-reported outcomes (ePRO) with triggered alerts as an add-on to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolstrup, Lærke K., Pappot, Helle, Bastholt, Lars, Möller, Sören, Dieperink, Karin B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782960/
https://www.ncbi.nlm.nih.gov/pubmed/35061112
http://dx.doi.org/10.1186/s41687-022-00414-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782960/
https://www.ncbi.nlm.nih.gov/pubmed/35061112
http://dx.doi.org/10.1186/s41687-022-00414-5

Ejemplares similares